Harumi Shimizu

1.4k total citations · 1 hit paper
9 papers, 1.1k citations indexed

About

Harumi Shimizu is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Harumi Shimizu has authored 9 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 2 papers in Biotechnology. Recurrent topics in Harumi Shimizu's work include Cancer-related Molecular Pathways (9 papers), Ubiquitin and proteasome pathways (7 papers) and RNA modifications and cancer (2 papers). Harumi Shimizu is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Ubiquitin and proteasome pathways (7 papers) and RNA modifications and cancer (2 papers). Harumi Shimizu collaborates with scholars based in United Kingdom and United States. Harumi Shimizu's co-authors include David Dornan, Ted R. Hupp, Vishva M. Dixit, Gretchen Frantz, Patrick J. Dowd, David Arnott, Hartmut Koeppen, Ingrid E. Wertz, Amanda Smith and Lindsay Burch and has published in prestigious journals such as Nature, Science and Journal of Biological Chemistry.

In The Last Decade

Harumi Shimizu

9 papers receiving 1.1k citations

Hit Papers

The ubiquitin ligase COP1 is a critical negative regulato... 2004 2026 2011 2018 2004 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harumi Shimizu United Kingdom 9 939 741 181 142 98 9 1.1k
Linghu Nie United States 15 668 0.7× 470 0.6× 134 0.7× 100 0.7× 108 1.1× 18 843
Yaron Pereg Israel 13 733 0.8× 541 0.7× 146 0.8× 91 0.6× 108 1.1× 18 942
Rory Geyer United States 14 1.1k 1.2× 582 0.8× 220 1.2× 112 0.8× 222 2.3× 15 1.3k
Dganit Shkedy Israel 10 1.2k 1.2× 941 1.3× 257 1.4× 141 1.0× 220 2.2× 11 1.3k
Marco M. Candeias France 16 747 0.8× 482 0.7× 210 1.2× 72 0.5× 119 1.2× 18 944
A Cook United Kingdom 14 936 1.0× 696 0.9× 170 0.9× 167 1.2× 59 0.6× 15 1.3k
Hestia Mellert United States 15 1.8k 1.9× 736 1.0× 352 1.9× 65 0.5× 114 1.2× 31 2.1k
Marie‐Jeanne Pillaire France 20 1.1k 1.2× 367 0.5× 294 1.6× 38 0.3× 107 1.1× 33 1.3k
Anita Lau Hong Kong 13 730 0.8× 546 0.7× 111 0.6× 124 0.9× 206 2.1× 14 850
Rosa Luna Spain 24 1.7k 1.8× 360 0.5× 213 1.2× 74 0.5× 168 1.7× 40 2.0k

Countries citing papers authored by Harumi Shimizu

Since Specialization
Citations

This map shows the geographic impact of Harumi Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harumi Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harumi Shimizu more than expected).

Fields of papers citing papers by Harumi Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harumi Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harumi Shimizu. The network helps show where Harumi Shimizu may publish in the future.

Co-authorship network of co-authors of Harumi Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Harumi Shimizu. A scholar is included among the top collaborators of Harumi Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harumi Shimizu. Harumi Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Shimizu, Harumi, David Saliba, Maura Wallace, et al.. (2006). Destabilizing missense mutations in the tumour suppressor protein p53 enhance its ubiquitination in vitro and in vivo. Biochemical Journal. 397(2). 355–367. 23 indexed citations
2.
Dornan, David, Harumi Shimizu, Michael Eby, et al.. (2006). ATM Engages Autodegradation of the E3 Ubiquitin Ligase COP1 After DNA Damage. Science. 313(5790). 1122–1126. 112 indexed citations
3.
Dornan, David, et al.. (2004). Interferon Regulatory Factor 1 Binding to p300 Stimulates DNA-Dependent Acetylation of p53. Molecular and Cellular Biology. 24(22). 10083–10098. 65 indexed citations
4.
Burch, Lindsay, Harumi Shimizu, Amanda Smith, Cam Patterson, & Ted R. Hupp. (2004). Expansion of Protein Interaction Maps by Phage Peptide Display Using MDM2 as a Prototypical Conformationally Flexible Target Protein. Journal of Molecular Biology. 337(1). 129–145. 24 indexed citations
5.
Dornan, David, Ingrid E. Wertz, Harumi Shimizu, et al.. (2004). The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature. 429(6987). 86–92. 568 indexed citations breakdown →
6.
Dornan, David, Harumi Shimizu, Lindsay Burch, Amanda Smith, & Ted R. Hupp. (2003). The Proline Repeat Domain of p53 Binds Directly to the Transcriptional Coactivator p300 and Allosterically Controls DNA-Dependent Acetylation of p53. Molecular and Cellular Biology. 23(23). 8846–8861. 87 indexed citations
7.
Dornan, David, Harumi Shimizu, Neil D. Perkins, & Ted R. Hupp. (2003). DNA-dependent Acetylation of p53 by the Transcription Coactivator p300. Journal of Biological Chemistry. 278(15). 13431–13441. 92 indexed citations
8.
Shimizu, Harumi & Ted R. Hupp. (2003). Intrasteric regulation of MDM2. Trends in Biochemical Sciences. 28(7). 346–349. 24 indexed citations
9.
Shimizu, Harumi, Lindsay Burch, Amanda Smith, et al.. (2002). The Conformationally Flexible S9–S10 Linker Region in the Core Domain of p53 Contains a Novel MDM2 Binding Site Whose Mutation Increases Ubiquitination of p53 in Vivo. Journal of Biological Chemistry. 277(32). 28446–28458. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026